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Ectopic Pregnancies (EP) arise in 1% of spontaneous conceptions [1], increasing to an incidence 
of 2-5% after In Vitro Fertilization (IVF) [2]. The origin of EP is unknown, although a number of 
risk factors have been identified. These include previous ectopic pregnancy [3], pelvic surgery or 
previous tubal surgery, peritonitis, tubal factors (pelvic inflammatory disease, or hydrosalpinx) [4], 
a previous genital C. trachomatis infection [5], recurrent miscarriage [6], being a heavy smoker, 
(defined as someone who smokes more than 10 cigarettes per day [7], advanced maternal age [8], 
Mullerian anomalies [9], adenomyosis [10], or multiple myomas [11]. In an infertile population, 
the main risk factor is the tubal factor, which markedly increases the rate of ectopic pregnancy (RR: 
1.25) [2]. 
During natural reproduction, the embryo migrates from the Fallopian tube to the endometrium 
before implanting. However, in IVF, the embryo is directly and artificially placed into the uterine 
cavity. Subsequently, uterine peristalsis can displace the embryo into the Fallopian tube, or cornua, 
as demonstrated for 11 of 112 patients for whom the uterine peristaltic wave frequency was measured 
during the mock embryo transfer [12].
Uterine peristalsis is demonstrably stronger during cycles of controlled ovarian hyper 
stimulation compared to natural cycles, with the peristaltic wave frequency correlating positively 
with levels of serum estradiol (E2), and negatively with progesterone (P4) levels. This phenomenon, 
incurred by a physiologic range of steroid hormone concentrations [13], suggests a potentially 
relevant conditioning effect at the embryo implantation site. Supra-physiologic levels of E2 and 
P4 can modify endometrial receptivity, and have a detrimental effect on the luteal phase [14]. 
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Abstract
Introduction: Several independent risk factors of Ectopic Pregnancy (EP) have been described to date. 
Nevertheless, estradiol and progesterone have not been related to ectopic pregnancy, although there is 
biological rationale to think about them as possible candidates. Our aim was to correlate the incidence of EP with 
levels of estradiol (E2) and progesterone (P4), measured on two days (hCG day, and seven days later (hCG+7)), 
including the differences and ratios of these concentrations, between the two time-points.
Material and methods: Retrospective cohort study of 578 patients undergoing fresh embryo transfer after 
IVF (100 cycles), ICSI (508 cycles) and IVF/ICSI (64 cycles) without risk of EP, between January 2005 and 
December 2015. We evaluated EP incidence (10 ectopic pregnancies) in fresh embryo transfers according 
to estradiol and progesterone levels on hCG day (hCGd) and seven days later (hCG+7) and their variation 
between both. The proportions were compared using the chi-square test or Fisher’s exact test and the means 
were compared using T-test or ANOVA. To determine the accuracy of each studied variable receiver-operating 
curves were built.
Results: We identified a trend towards an increased risk of EP as progesterone levels rose on hCGd 
(p=0.020) and an association of progesterone values >1.89ng/ml on hCGd with EP (OR 6.8). An increased risk 
of EP when the difference of estradiol between hCGd and hCG+7 was either <39pg/mL, or >745pg/mL (p=0.001) 
was also found. ROC analysis only resulted significant for a moderate/good predictive ability for progesterone 
values on hCGd (AUC: 0.694).
Discussion: We conclude that these measurements are sufficient to identify patients at a high risk of EP. 
These hormone levels on specific days, leading us to define proper strategies to prevent EP risks in IVF. Further 
studies should design to prove this hypothesis.
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Hormonal factors appear to modify smooth muscle activity, and 
could underlie certain cases of EP not associated with structural 
tubal or uterine abnormalities [15]. Furthermore, those patients 
with polycystic ovarian syndrome (PCOS), who would be expected 
to manifest higher E2 levels, experience higher EP rates after fresh 
embryo transfer compared to non-PCOS patients [16]. 
Since IVF first began, it has been postulated that an uncalculated 
percentage of embryos transferred into the uterine cavity migrate 
to the Fallopian tubes, that, under normal conditions, are propelled 
back into the uterine cavity [17]. In support of this are data from an 
experimental study to evaluate embryo transfer, in which a radio-
opaque dye moved to the Fallopian tubes in 38.2% of cases [18]. 
The controlled Fallopian tube cilia beat plays a role in facilitating 
the transport of the embryo to its implantation site. Interestingly, in 
vitro studies with Fallopian tube epithelial samples showed that P4 
and E2 modify ciliary activity, offering a plausible explanation for the 
association between hormone levels and EP. Higher progesterone 
levels may cause ciliary dysfunction and EP [19]. While the effect of 
E2 on receptors in the tubal epithelium remains unknown, E2 has 
been shown to be involved in abnormal embryo implantation in the 
Fallopian tube [20]. Furthermore, P4 alone slows ciliary activity, and 
its concomitant use blocked the effect of E2 in ovum transport [21].
E2 and P4 levels are typically elevated during IVF, especially on 
the day on which hCG is administered. The largest series on this issue 
speculated that ovarian stimulation is associated with an increased 
risk of EP [22]. However, we currently lack studies with sufficient 
statistical power (due primarily to low EP prevalence) with which to 
associate luteal phase hormone levels with EP. 
Our aim was to evaluate the influence of the absolute 
concentrations of E2 and P4, together with their variation and ratios 
on hCGd and seven days later (hCG+7), on the incidence of EP. We 
only included women with no history of factors related with EP.
Capsule: Ectopic pregnancies are more frequent when early luteal 
estradiol levels vary markedly compared to the day of hCG and when 
progesterone levels are elevated on that day. 
Material and Methods
In a retrospective cohort study, we reviewed the fresh embryo 
transfers in our IVF programme using the IVI Vigo and Almeria 
databases. From January 2005 to December 2014, we included 578 
women under their 40 (672 cycles), with no history of factors related 
to EP who underwent an IVF cycle without PGS. These factors include 
previous EP, pelvic surgery or previous tubal surgery, peritonitis, tubal 
factors (pelvic inflammatory disease or hydrosalpinx), a previous 
genital infection by C. trachomatis, recurrent miscarriage, heavy 
smoker (defined as someone who smokes more than 10 cigarettes per 
day), advanced maternal age (≥40 years old), Müllerian anomalies, 
adenomyosis, or multiple myomas. All these factors, as well as a Body 
Mass Index (BMI) of higher than 30 kg/m2, were considered exclusion 
criteria. All patients had undergone a normal hysterosalpingography 
and/or a laparoscopy to confirm normal tubes. Cycles using donated 
oocytes were excluded. An Institutional review board approval for 
this study was granted by our ethical committee. Even though it is not 
mandatory, due to the study design, we registered it at clinicaltrials.
gov (NCT02793089).
As is clinically routine in IVI Vigo and Almeria, we measured 
E2 and P4 levels on hCGd, and during the early luteal phase in all 
patients in order to establish their treatment schedule [23,24]. We 
studied the correlation of EP risk with both E2and P4 levels, as well 
as with the ratio of E2/P4. These correlates were derived for each 
hormone, or ratio of hormones, for both time points (hCGd and 
hCG+7), including an added category of their variation from one 
time point to the other. E2/P4 ratios were calculated as (E2 x P4)/1000 
level. Due to the absence of pre-established clinical thresholds, 
cycles were categorized into quartiles and deciles depending on E2 
and P4 values. Cycles were groupedde pending on the quartile to 
which they belonged, showing either central (2nd+3thquartile),or 
eccentric values (1st+4rd quartile). Cycles were additionally classified 
according to their decile categorization, with the uppermost values 
included in the upper decile, and the lowest, in the bottom decile.
Ovarian Stimulation
For controlled ovarian hyper-stimulation, Gonadotropin 
Releasing Hormone (GnRH) antagonist protocols were used, as 
previously described [25].
Gonadotropin was given once ovarian quiescence had been 
confirmed. Daily doses of GnRH antagonist (Cetrotide, 0.25 mg; 
Merck-Serono, Madrid, Spain or Orgalutran, 0.25 mg; Merck Sharp 
& Dohme Limited, Hertfordshire, UK) were administered until the 
leading follicle reached 14 mm in mean diameter. Once three or more 
follicles reached 17 mm in diameter, hCG (Ovitrelle, 250 μg; Merck-
Serono, Madrid, Spain) was administered, and, as before, oocyte 
retrieval was scheduled for 36 hours later. Patients with less than 3 
follicles over 17mm, were excluded of the study. 
The Luteal phase was supported with the administration of 600 
mg (200 mg x 3) of vaginal P4 (Progeffik, 200mg; Effik, France) 
pessaries [26].
Serum E2 and P4 levels were also measured on the morning of 
hCG administration, and again 7 days later. Samples were tested with 
a micro particle enzyme immunoassay Access System (Beckman 
Coulter S.A., Madrid, Spain). The serum E2 kit had a sensitivity of 23 
pg/mL, and comparison with mass spectrometry showed a correlation 
coefficient of 0.99. The serum P4 kit had a sensitivity of 0.08 ng/mL, 
and a correlation coefficient of 0.978.
We increased the doses of progesterone to 1200 mg/day when the 
level was lower than 10 ng/mL. Additionally, in patients with a severe 
E2 decline (<200pg/mL), 4mg of estradiol valerate at a daily dosewere 
added [24].
Oocyte pickup, fertilization, and embryo culture
Oocytes were collected by follicle aspiration. Beinga nine-year 
retrospective study (i.e. a prolonged investigation, prone to changes 
in materials), two different media were employed by the clinics. 
From 2005 to 2009, all procedures were performed using Vitro life 
media (Kungsbacka, Sweden), and from 2010 to 2014, all gametes 
and embryos were handled and cultured in Global (Life Global, 
Canada) media. To summarise, the oocytes were aspirated, washed 
in a buffered media then cultured in media for fertilization at 37ºC, 
under a 6.0% CO2 and 20.0% O2 atmosphere for 3h before oocyte 
denudation. Granulosa cells were then removed from oocytes by 
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mechanical pipetting in 1:1 hyaluronidase (80 IU/ml), in buffered 
media, prior to ICSI.
ICSI was carried out one hour after oocyte denudation, under an 
Olympus IX71 microscope, in buffered media, at X400 magnification. 
Then microinjected oocytes were cultured in standard incubators 
at 37.0ºC, 6.0% CO2, and 20.0%O2 atmosphere. When classic IVF 
was performed, oocytes were suspended in 50 microlitre drops and 
inseminated with 100,000 sperm cells, as previously described [27]. 
Embryo selection was performed according to the recommendations 
stated by the Asociación para el Estudio de la Biología de la 
Reproducción (ASEBIR) [28]. Assisted Hatching was not performed 
in any embryo. 
Embryo transfer
Embryo Transfer (ET) was performed either on day 3, or day 5 
of embryo development after oocyte pick up. A maximum of three 
embryos were transferred, as per Spanish legislation, although single 
and double embryo transfers were performed on almost all patients. 
We made an analysis to establish our own threshold of premature 
luteinization. Values were considered unacceptably high, when one 
standard deviation values exceed up the media [29]. To confirm 
this, we studied 2,144 samples from patients from our clinic using 
the Access 2 Immunoassays System (Beckman Isaza, Madrid, Spain). 
On hCGd, we found an average of P4 of 1.236 ng/mL and a standard 
deviation of 0.754. Therefore, the premature luteinization was 
considered above 1.99ng/mL.
The embryo transfer was not performed if the P4 level onhCGd 
was ≥ 1.99 ng/mL.
Before ET, we requested that patients drank liquids to keep their 
bladders full. Trans-abdominal sonography was performed during 
the procedure to monitor the catheter position in the uterine cavity. A 
sterile speculum (bivalve speculum) was introduced into the vagina, 
which was opened to expose the ectocervix. This had previously 
been cleaned with a sterile cotton swab soaked in flushing media. 
Embryos were then loaded in an Emtrac Delphin or Emtrac Plus 
embryo transfer catheter (Gynetics medical products. N.V., Lommel, 
Belgium), by the embryologist as follows: Firstly, the ET catheter 
was connected to a 1ml syringe (BD Plastipak, Beckton Dickinson; 
Madrid)
then flushed with embryo culture medium twice. Secondly, the 
catheter was filled with embryo culture medium, followed by 5 μl 
of air, then, 20 μl of culture medium containing the embryos, and 
finally another 5 μl of air at the tip of the catheter. Once the embryos 
were loaded into the catheter, the embryologist carried it to the 
theatre, which is adjacent to the IVF laboratory, and passed it to the 
gynecologist, who inserted it into the lower uterine segment, passing 
through the ectocervix. The catheter can be visualized because of its 
refringence, and was moved to a distance not less than 10mm from the 
fundus [30]. The syringe plunger was then firmly pressed to release 20 
μl of culture medium containing the embryos into the uterine cavity, 
followed by a 45° rotation, and removal of the catheter. The catheter 
was then checked in the IVF laboratory to confirm embryo delivery. 
ET procedures were classified as easy, moderate, or difficult. Easy 
transfers were made with the Emtrac Delphin catheter without force, 
or additional instrumentation. Moderate transfer implied use of the 
Emtrac Plus Catheter. Finally, a difficult transfer was that in which 
either the tenaculum was employed, or was a transfer that required 
more than one ET attempt. In this case, patients were encouraged 
to either drink more liquids, or empty their bladder, before the next 
attempt [31].
EP confirmation
The serum β-hCG was either measured 11 days after the blastocyst 
transfer or 13 days after embryo cleavage transfer. Clinical pregnancy 
was confirmed two weeks later if the existence of an embryo with a 
heartbeat was detected with a transvaginal ultrasound. An ongoing 
pregnancy was defined as a pregnancy that had developed beyond 12 
weeks. Early pregnancy loss was defined as that proportion of patients 
with an initial positive β-hCG, in whom pregnancy failed to develop 
by 12 weeks of gestation.
EP was suspected when no intrauterine sac was detected with 
a transvaginal ultrasound at 5.5 weeks of gestational age [32], even 
if there were no significant abnormalities in the adnexa, and when 
serum β-hCG was >1000 IU/L [33]. We only consider cases of 
confirmed EP diagnosis by the presence of an embryo or yolk sac 
outside of the uterine cavity. [34].
Statistical analyses
For statistical analyses and after confirming the normal 
distribution of the data herein collected with Shapiro-Wilk Test, the 
chi-square test, or Fisher’s exact test were applied where appropriate 
to compare proportions and T-test or ANOVA to compare means. 
The Statistics Package for Social Sciences version 22 was employed 
for all statistical analyses. Odd ratios and their corresponding 95% 
Confidence Intervals (CIs) between categories were also computed to 
provide an estimation of the association strength. Receiver-Operating 
Curves (ROC) were plotted in order to determine the accuracy of each 
studied variable in predicting EP.P values of <.05 were considered to 
be statistically significant.
Results
Demographics, patients and cycles
The mean ages of our female and male patients were 35.7 years 
95%CI(35.4-36.0), and 37.8 years 95% CI (37.4-38.2), respectively. 
The mean female BMI was 23.5 kg/m2 95% CI (23.2-23.8).The 
prevalence of non-smokers among women included in our study was 
86.2%, with light smokers comprising 13.8% of the total cycles. The 
reasons given for undergoing IV Fincluded:a maternal age of over 37 
(58 cases, 8.6%), a low response to conventional ovarian stimulation 
(83 cases, 12.3%), polycystic ovarian syndrome (100 cases, 14.9%), 
or mild endometriosis (82 cases, 12.2%).The remaining patients 
presented no gynecological condition related to female infertility. 
Fifty-three patients had already had a previous pregnancy (9.1%).
Sperm quality, expressed as mean total motile spermatozoa in 
fresh ejaculates, was 79.5 million/ejaculate 95% CI (68.6-90.3), falling 
to 0.67 mill/sample 95% CI (0.44-0.91) after sperm preparation in the 
laboratory.
The mean (all subsequent values are means) number of 
stimulation days was9.9 95% CI (9.8-10.1), with a FSH dose of 1826.1 
units 95% CI (1754.7-1897.6) and hMG dose of 700.9 units 95% CI 
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(647.5-754.2).The endometrial thickness was 10.2 mm 95% CI (10.0-
10.4) and the number of retrieved oocytes 10.2 95% CI (9.7-10.7),with 
8.5 95% CI(8.0-8.9) in metaphase II. In100 cases, fertilization was 
carried out using the classical IVF method (14.9%), while 508 cases 
fertilization was though ICSI (75.6%), with both techniques used 
simultaneously in 64 cases (9.5%). 
A mean value (again, all subsequent values are means) of 5.9 
oocytes 95% CI (5.7-6.2) were successfully fertilized, and 1.8 embryos 
transferred 95% CI (1.8-1.9), 1.1 95% CI (1.0-1.2) oocytes frozen. 
Easy embryo transfers occurred in 589 cases (87.6%), with moderate 
difficulty encountered in 22 cases (3.3%) and severe difficulties in 
4 (0.6%). In 57 cases (8.5%), the ET procedures were not recorded, 
which were excluded of the study. The majority (79.3%) of embryo 
transfers were performed at day three of embryo cleavage, and 8 
ectopic pregnancies where found in this group, while only two EP 
where found in those patients who were transferred day 5 embryos. 
The clinical pregnancy rate per transfer was 46% 95% CI (42.3-49.8), 
with an implantation rate of 25.6% 95% CI (22.9-28.3). The early 
pregnancy loss rate per transfer was 7.2% 95% CI (5.3-9.1), and the 
ectopic pregnancy rate per transfer was 1.5% 95% CI (0.6-2.4).
Comparisons of E2 and P4 levels between EP and no EP 
(inclusive of negative results and normal pregnancies)
E2 levels on hCGd and hCG+7 and their differences, were 
comparable in cycles resulting in EP compared to cycles that did not. 
The mean E2 concentrations on hCGd (for EP positive vs. negative 
cycles) were 1454.7 pg/mL 95% CI (779.0-2130.4) vs. 1562.7pg/
mL95% CI (1484.56-1640.79). Seven days later (hCG+7), these values 
were 1024.1 pg/mL95% CI (625.6-1422.6) vs. 1176.3 pg/mL95% CI 
(1109.5-1242.6), with mean differences (between the two time points) 
of 430.6 pg/mL95% CI (0-899.1) vs. 390pg/mL 95% CI (325.4-456.1). 
The mean P4 concentrations on hCGd were 1.5 ng/mL95% CI 
(1.1-2.0) vs. 1.1 ng/mL95% CI (1.1-1.1) for cycles with and without EP; 
these differences were found to be statistically significant (p=0.036). 
However, values for P4 athCG+7, and the variation between values 
recorded on hCGd vs. hCG+7, were statistically comparable. 
Specifically, on hCG+7, P4 was 86.2 ng/mL 95% CI (26.6-145.7) 
vs. 81.8 ng/mL 95%C I (76.6-86.9) for EP versus no EP; the mean 
fluctuation in concentration of P4between both days was 84.6ng/mL 
95%CI (25.4-143.9) vs. 80.7 ng/mL95% CI (75.6-85.8) for EP positive 
vs. negative and no EP cases, respectively. 
Regarding the E2/P4 ratio, all parameters were statistically 
comparable when comparing cases of EP, and no EP. On hCGd, 
the relevant mean values were (again for EP positive versus negative 
cycles) 1020.6 95%CI (605.1-1436.2) vs. 1728.1 95%CI (1612.4-
1843.9), changing to 1003.8 95% CI (589.4-1418.2) vs. 1708.9 95% CI 
(1593.5-1824.3) for hCG+7. The differences between the time points 
were 16.8 95%CI (8.1-25.6) vs. 19.2 95%CI (17.8-20.6).
E2 and P4 relationship between EP and normal pregnancies 
(NP)
When we compared the main outcome measures, in cases of EP 
versus a normal implanted pregnancy, E2 on hCGd was 1454.7pg/
mL 95% CI (779.0-2130.4) vs. 1583.5pg/mL 95% CI (1468.7-1698.3), 
decreasing to 1024.1 pg/mL 95% CI (625.6-1422.6) on hCG+7 vs. 
1304.3pg/mL 95% CI (1200.6-1408.1). The respective differences in 
concentration were 430.6 pg/mL 95% CI (0-899.1) vs. 285.5pg/mL 
95% CI (191.7-379.3).
The data for P4 (i.e. EP versus a normal implanted pregnancy) 
on hCGd were 1.5ng/mL 95% CI (1.1-2.0) vs. 1.1ng/mL (1.0-1.2), 
and 86.2ng/mL 95% CI (26.6-145.7) on hCG+ 7 vs. 90.2ng/mL 95% 
CI (81.6-99.2). The respective variations in concentration over these 
time points were 84.6ng/mL 95% CI (25.4-143.9) vs. 89.3ng/mL 95% 
CI (80.5-98.1) for EP and NP respectively. The P4 value on hCGd was 
statistically significant (p=0.036).
Regarding the E2/P4 ratio, a similar relationship was confirmed 
between groups, with all parameters statistically comparable. The 
respective values for EP positive cycles versus normal implanted 
pregnancies were, on hCGd, 1020.6 95% CI (605.1-1436.2) vs. 1689.9 
95% CI (1561.0-1818.8), on hCG+ 71003. 8 95% CI (589.4-1418.2) 
vs. 1669.7 95% CI (1541.3-1798.0) being the differences 16.8 95% CI 
(8.1-25.6) vs. 20.2 95% CI (17.9-22.5) respectively.
Correlation between E2 and EP
As shown in Table 1, the absolute levels of E2 on hCGd, seemed 
not to influence the risk of EP, since no trend towards either increased 
or decreased rates of EP were noted in the quartiles, nor obvious 
differences in the central/eccentric categories, nor highest or lowest 
values. In terms of E2 levels found on hCG+7, a similar result was 
noted, although no EP was registered at values below 338pg/mL, or 
above 2,304pg/mL.
When taking into account the E2 fluctuation between days, an 
effect was detected. We noted an increased risk of EP if patients showed 
variations of below 39pg/mL, or above 745pg/mL, meaning that 
outlier changes in hormonal concentration exhibited a significantly 
higher chance of EP. Moreover, we did not identify a single case of EP 
below a decreased value of -436.0 (between time points).
Correlation between P4 concentration and EP
Interestingly, there is a noticeable trend that was statistically 
significant, in which elevated P4 levels on hCGd presented an 
increased risk of EP (Table 2: test for trend p=0.020), although 
specific inter-group differences were not identified. Those P4 values 
on hCGd, lying outside of the central values, presented statistically 
comparable rates of EP. P4 values were particularly related to EP 
when belonging to the last decile (i.e. extremely high values for P4, 
in excess of 1.89 ng/mL), with these data providing an OR indicating 
an approximately 7 fold effect. No link with EP was observed for data 
falling within the first decile (i.e. below 0.51 ng/mL).
When analyzing the data for hCG+7, as well as the differences in 
P4 concentration between both days, there was neither an observable 
trend, nor any change regardless of the category analyzed, indicating 
a lack of effect on EP rate.
E2/P4 ratio on hCGd, hCG+7 and variation in EP incidence
As seen in Table 3, the ratio of E2/P4 appeared not to be related 
to the risk of EP, neither on hCGd, nor hCG+7.When analyzing 
the differences between both days, we found a trend emerging in 
that the risk of EP decreased, as the difference in values increased, 
although this effect was not found to be statistically significant. No 
EPs occurred when E2/P4 values on hCGd were above 3,131 or below 
5.34 on hCG+7.
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Table 1: Risk of EP according to E2 concentration on hCGd, hCG+7, and its variation. Data are expressed as proportions or odds ratios (OR) with 95%CI. Regarding 
all ranges, the value included corresponded always to the higher within the range (example, lower to 857.7, has 857.7 included, and this figure is not included within 
the subsequent category).
E2 hCGd Range Cycles Ectopic pregnancy OR p value
1st Quartile Lower to 857.7 167 4 (2.3%) Ref.  
2nd Quartile 857.7-1372.5 169 1 (0.6%) 0.25 (0.03-2.23) Ns
3rd Quartile 1372.5-2012 168 3 (1.8%) 0.75 (0.16-3.38) Ns
4th Quartile 2012 to higher 168 2 (1.2%) 0.50 (0.08-2.74) Ns
      
Central values (2nd+3rd QT)  337 4 (1.2%) Ref.  
Eccentric values (1st+4th QT)  335 6 (1.8%) 1.51 (0.42-5.40) Ns
      
Lower 90th percentile Lower to 2859.0 605 9 (1.5%) Ref.  
Upper 10thpercentile (extreme val.) 2859.0 to higher 67 1 (1.5%) 1.00 (0.13-8.05) Ns
      
Upper 90th percentile 552.0 to higher 604 9 (1.5%) Ref.  
Lower 10th percentile (extreme val.) Lower to 552.0 68 1 (1.4%) 0.99 (0.13-8.04) Ns
      
E2 hCG +7 day Range Cycles Ectopic pregnancy OR p value
1st Quartile Lower to 561 168 3 (1.8%) Ref.  
2nd Quartile 561-983 167 3 (1.8%) 1.01 (0.20-5.05) Ns
3rd Quartile 983-1491 171 1 (0.6%) 0.33 (0.03-3.18) Ns
4th Quartile 1491 to higher 166 3 (1.8%) 1.01 (0.20-5.07) Ns
      
Central values (2nd+3rd QT)  338 4 (1.2%) Ref.  
Eccentric values (1st+4th QT)  334 6 (1.8%) 1.52 (0.43-5.43) Ns
      
Lower 90th percentile Lower to 2304.0 604 10 (1.6%) Ref.  
Upper 10th percentile (extreme val.) 2304.0 to higher 68 0 (0%) NA Ns
      
Upper 90th percentile Higher to 338.0 603 10 (1.6%) Ref.  
Lower 10th percentile (extreme val.) 338.0 to lower 69 0 (0%) NA Ns
      
E2 variation hCGd – hCGd+7 Range Cycles Ectopic pregnancy OR p value
1st Quartile Lower to 39 165 6 (3.5%) Ref.  
2nd Quartile 39-328 170 0 (0.0%) NA Ns
3rd Quartile 328-745 171 0 (0.0%) NA Ns
4th Quartile 745 to higher 166 4 (2.4%) 0.66 (0.18-2.39) Ns
      
Central values (2nd+3rd QT)  341 0 (0.0%) Ref.  
Eccentric values (1st+4th QT)  331 10 (2.9%) NA 0.001
      
Lower 90th percentile Lower to 1321.0 605 9 (1.5%) Ref.  
Upper 10th percentile (extreme val.) 1321.0 to higher 67 1 (1.5%) 1.00 (0.13-8.04) Ns
      
Upper 90th percentile Higher to -436.0 603 10 (1.6%) Ref.  
Lower 10th percentile (extreme val.) -436.0 to lower 69 0 (0%) NA Ns
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Table 2: Risk of EP depending on the P4 level on hCGd, hCG+7, and its variation. Data are expressed as proportions or odds ratios (OR) with 95%CI.
P4 hCGd Range Cycles Ectopic pregnancy OR p value
1st Quartile Lower to 0.72 171 1 (0.6%) Ref.  
2nd Quartile 0.72-1.0 162 1 (0.6%) 1.05 (0.06-16.94) Ns
3rd Quartile 1.0-1.44 166 2 (1.2%) 2.06 (0.27-2.72) Ns
4th Quartile 1.44 to higher 156 6 (3.7%) 6.57 (0.78-55.6) Ns
      
Central values (2nd+3rd QT)  328 3 (0.9%) Ref.  
Eccentric values (1st+4th QT)  327 7 (2.1%) 2.34  (0.60-9.13) Ns
      
Lower 90th percentile Lower to 1.89 611 6 (1.0%) Ref.  
Upper 10th percentile (extreme val.) 1.89 to higher 61 4 (6.3%) 6.8 (1.87-24.8) 0.01
      
Upper 90th percentile Higher to 0.51 603 10 (1.6%) Ref.  
Lower 10th percentile (extreme val.) 0.51 to Lower 69 0 (0%) NA Ns
      
P4 D+7 day Range Cycles Ectopic pregnancy OR p value
1st Quartile Lower to 40.4 236 6 (2.5%) Ref.  
2nd Quartile 40.4-60.0 100 0 (0%) NA Ns
3rd Quartile 60.0-105.2 159 2 (1.2%) 0.49 (0.10-2.50) Ns
4th Quartile 105.2 to higher 165 2 (1.2%) 0.48 (0.10-2.39) Ns
      
Central values (2nd+3rd QT)  259 2 (0.8%) Ref.  
Eccentric values (1st+4th QT)  401 8 (2.0%) 2.58 (0.54-12.26) Ns
      
Lower 90th percentile Lower to 153.4 607 8 (1.3%) Ref.  
Upper 10th percentile (extreme val.) 153.4 to higher 65 2 (3.0%) 2.34 (0.49-11.23) Ns
      
Upper 90th percentile Higher to 33.7 606 9 (1.5%) Ref.  
Lower 10th percentile (extreme val.) 33.7 to Lower 66 1 (1.5%) 1.02 (0.13-8.18) Ns
      
P4 variation hCGd+7 – hCGd Range Cycles Ectopic pregnancy OR p value
1st Quartile Lower to 39.2 158 5 (3.0%) Ref.  
2nd Quartile 39.2-58.8 162 1 (0.6%) 0.20 (0.02-1.70) Ns
3rd Quartile 58.8-105.3 161 2 (1.2%) 0.40 (0.07-2.07) Ns
4th Quartile 105.3 to higher 161 2 (1.2%) 0.40 (0.07-2.07) Ns
      
Central values (2nd+3rd QT)  323 3 (0.9%) Ref.  
Eccentric values (1st+4th QT)  320 7 (2.1%) 0.43 (0.11-0.66) Ns
      
Lower 90th percentile Lower to 153.28 609 8 (1.3%) Ref.  
Upper 10th percentile (extreme val.) 153.28 to higher 63 2 (3.1%) 2.42 (0.50-11.63) Ns
      
Upper 90th percentile Higher to 33.62 608 9 (1.5%) Ref.  
Lower 10th percentile (extreme val.) 33.62 to lower 64 1 (1.5%) 1.06 (0.13-8.47) Ns
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Table 3: Risk of EP depending on the E2/P4 ratios on hCGd, hCG+7, and their variation. Data are expressed as proportions or odds ratios (OR) with 95% CI.
E2/P4 hCGd Range Cycles Ectopic pregnancy OR p value
1st Quartile Lower to 820.7 161 5 (3.0%) Ref.
2nd Quartile 820.7-1319.15 164 2 (1.2%) 0.39 (0.08-2.07) Ns
3rd Quartile 1319.15-2134.5 162 3 (1.8%) 0.60 (0.14-2.55) Ns
4th Quartile 2134.5 to higher 167 0 (0 %) NA Ns
Central values (2nd+3rd QT) 326 5 (1.5%) Ref.
Eccentric values (1st+4th QT) 329 5 (1.5%) 0.99 (0.28-3.46) Ns
Lower 90th percentile Lower to 3131.57 606  10 (1.6%) Ref.
Upper 10th percentile (extreme val.) 3131.57 to higher 66 0 (0%) NA Ns
Upper 90th percentile Higher to 536.3 609 8 (1.3%) Ref.
Lower 10th percentile (extreme val) 536.3 to lower 63 2 (3.1%) 2.42 (0.50-11.63) Ns
E2/P4 hCG+7 day Range Cycles Ectopic pregnancy OR p value
1st Quartile Lower to 8.32 166 2 (1.2%) Ref.
2nd Quartile 8.32- 14.14 163 4 (2.4%) 2.03 (0.37-11.23) Ns
3rd Quartile 14.14-23.44 166 2 (1.2%) 1.00 (0.14-7.19) Ns
4th Quartile 23.44 to higher 165 2 (1.2%) 1.01 (0.14-7.24) Ns
Central values (2nd+3rd QT) 329 6 (1.8%) Ref.
Eccentric values (1st+4th QT) 331 4 (1.2%) 0.66 (0.19-2.37) Ns
Lower 90th percentile Lower to 38.97 606 9 (1.5%) Ref.
Upper 10th percentile (extreme val.) 38.97 to higher 66 1 (1.5%) 1.02 (0.13-8.18)
Upper 90th percentile Higher to 5.34 605 10 (1.6%) Ref.
Lower 10th percentile (extreme val) 5.34 to lower 67 0 (0%) NA Ns
E2/P4 variation hCGd – hCGd+7 Range Cycles Ectopic pregnancy OR p value
1st Quartile Lower to 799.59 157 5 (3.1%) Ref.
2nd Quartile 799.59-1302.67 162 2 (1.2%) 0.39 (0.07-2.04) Ns
3rd Quartile 1302.67-2094.10 161 2 (1.2%) 0.39 (0.07-2.04) Ns
4th Quartile 2094.10 to higher 162 1 (0.6%) 0.20 (0.02-1.68) Ns
Central values (2nd+3rd QT) 323 4 (1.2%) Ref.
Eccentric values (1st+4th QT) 320 6 (1.8%) 1.51 (0.42-5.42)
Lower 90th percentile Lower to 3088.15 607 10 (1.6%) Ref.
Upper 10th percentile (extreme val.) 3088.15 to higher 65 0 (0%) NA Ns
Upper 90th percentile Higher to 520.49 609 8 (1.3%) Ref.
Lower 10th percentile (extreme val) 520.49 to lower 63 2 (3.1%) 2.41 (0.52-11.63) Ns
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E2 and P4 levels on hCGd, hCG +7 and their predictive 
value
ROC curve analyses revealed (Supplemental Figure 1) that neither 
E2, P4 (inclusive of differences for both hormones over time), or their 
ratios (E2/P4), on either test day, provided any predictive power, 
except for a moderate to good predictive ability for P4 value, on the 
day of administration of hCG. For this metric (P4), the accuracy of 
its predictive power (the area under the curve (AUC) was almost 0.7.
Discussion
We found that EP occurred more frequently in fresh IVF cycles 
when an excessive fluctuation in hormone levels occurred at the early 
luteal phase compared to hCGd in patients without known EP risk 
factors. High P4 levels on hCGd were also associated to an increased 
risk of EP, with significant risks caused by extremely high values of 
P4.
The considerable diversity of individuals undergoing assisted 
reproductive treatments limits our ability to pinpoint the factors that 
predispose EP. This study was conducted with a selected population 
without any known EP risk factors, rather than a random sample, and 
it could explain why an IVF cycle without any apparent risk factors 
ends in EP.
We measured hormonal levels on day +7 from hCGd, as it 
corresponds to the peak level of P4 during luteal phase. Although it 
is controversial, several studies support taking the measurement of 
E2 and P4 during the luteal phase as they have a potential predictive 
value for P4 in IVF/ICSI [35]. A value of 9.4 ng/mL as single serum 
progesterone measurement in the luteal phase is a criterion of a 
potentially fertile cycle (“ovulation”) [36]. Furthermore, a serum 
P4 levels between 3 and 10ng/ml have been considered as low 
concentrations [37]. Some authors have found a beneficial effect 
to add estradiol to progesterone to support the luteal phase in IVF 
agonists cycles [38,39].
Conversely, there is no threshold for estradiol during luteal 
phase. A recent study shows that supplementation with P4 plus E2 for 
luteal phase is associated with a higher clinical pregnancy rate than 
progesterone alone in women undergoing IVF. [40].
When E2 ratio (day 0/day 8) was>5 (corresponding to 80% 
decline), implantation and pregnancy rates decreased significantly 
[24].
Agreed hormone thresholds that constitute high/low E2 and 
P4 levels at the mid luteal phase are unavailable. Therefore, to 
demonstrate the hormone variability for our patient cohort, they 
were categorized into four groups, based on percentiles. Patients in 
either of the outlying quartiles (the first or fourth) were considered to 
demonstrate aberrant levels of hormone variation between hCGd, and 
hCG+7. While we are aware that we lost information by categorizing 
in this fashion, we also gained accuracy with this strategy.
According to our data, a wide variation of E2values between 
hCGd and hCG+7 is associated with EP. In either group, when E2 
variation markedly increased or declined steeply (eccentric values, 
Table 1), the risk of EP was high. Specifically, altered levels of E2 of 
less than 39 pg/mL, or greater than 745 pg/mL (i.e. sharply divergent 
from the mean), were associated to significantly higher risks of EP.
In terms of high concentrations of E2, a supra-physiologic 
hormonal milieu could alter uterine contractile patterns as E2 levels 
rise at hCG+7 [41]. However, as yet, we do not know why a decrease 
of E2 would lead to a higher risk of EP. We would hypo the size 
that a sharp serum fall in E2 could modify endometrial receptivity, 
providing a plausible explanation for the link between low E2 levels 
and EP. 
The effect of E2 and P4 concentrations around the time of 
implantation as a cause of EP is not a novel proposition. In the 
early eighties, an unexplained spike in the incidence of EP was 
described in relation to ovarian stimulation, with the suggestion that 
an altered tubal peristalsis was to blame, due to elevated hormone 
concentrations [42,43]. This hypothesis would be plausible if the 
embryo moves outside of the uterine cavity after its transfer, causing 
its retention in the Fallopian tube. Supra-physiological E2 levels 
may cause disorganized uterine contractility, which could expel the 
embryos from the uterine cavity [44]. 
Uterine peristalsis exerts control over fluid migration after ET, with 
fluid displaced into the Fallopian tubes or the cornua of the uterus in 
9.8% of the cases. Also, the frequency of peristaltic waves significantly 
correlates with the distance the fluid moves [12]. Embryos placed in 
the intrauterine cavity using a combination of soft catheter and ultra 
sound do not always remain in situ [45]. Once the embryo reaches 
the tube, it should transit to the uterine cavity under the effects of 
regulatory mechanisms including endocrine regulation, mainly by 
ovarian steroids, as well as neuronal and paracrine regulation [46]. E2 
treatment accelerates ovum transport, whereas P4 slows the process, 
and induces a decrease in uterine peristalsis, especially for the cervix-
fundus waves, and during the luteal phase [47]. We did not find any 
relationship between the insemination technique and EP risk.
The high ratio between E2/P4 can increase the muscular tone of the 
isthmus, facilitating the retention of the embryo in the tube, whereas a 
low ratio may reduce tubal peristalsis delaying embryo transportation 
[15]. However, in our study we could find no correlation between 
the E2/P4 ratio and EP. We did however find a correlation between 
P4 levels on hCGd and EP risk. This finding is in agreement with 
previous studies, which demonstrated that patients with elevated E2 
and P4 on hCGd have significantly higher EP rates compared to the 
unexposed group [48]. Although controversial, some studies show 
adverse outcomes in Assisted Reproductive Techniques (ART) when 
the P4 level is high in the late follicular phase of ovarian stimulation 
[25]. We do not yet know the mechanisms whereby increased P4 
during the late follicular phase increases the risk of EP, but we would 
propose two theories. First, the premature endometrial maturation 
induced by P4 could lead to a non-receptive status provoked by an 
altered gene expression [49,50]. This may cause implantation at other 
locations. Secondly, uterine peristalsis may guide the embryo away 
from the uterus, with the embryo unable to return from the Fallopian 
tube. Exposure to a high P4 concentration during the late follicular 
phase could alter tubal peristalsis, as has been shown in experimental 
studies, leading to the retention of the embryo in the Fallopian tube 
[19,21]. However, this hypothesis is yet to be proven given that we 
neither measured uterine nor tubal peristalsis in the different groups. 
Additionally, the finding of a very low EP rate in treatments under 
constant hormonal conditions reinforces our theory. 
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Multiple studies have shown that EP is less common after frozen 
ET compared to fresh [51,52]. Incidence rates of 1.8% in fresh IVF 
cycles, and 1.4% in fresh ICSI cycles have been reported, versus 0.8% 
for frozen cycles [52]. To explain these findings, authors have raised 
the possibility that controlled ovarian hyper-stimulation (COH) 
adversely effects the endometrium. Meanwhile, the incidence of EP 
is lower in oocyte recipients, whose treatment is conducted without 
exposure to a supra-physiologic hormone milieu [53]. Interestingly, 
the number of oocytes retrieved [54], and embryos transferred, 
have been associated with a high risk of EP in a recent retrospective 
analysis [55]. Similarly, patients with Polycystic Ovarian Syndrome 
(PCOS), who likely generate a higher E2 level, manifest a higher EP 
rate after fresh embryo transfer compared to non-PCOS patients 
[16]. High levels of E2 at the early luteal phase may be the result 
of an elevated level of corpus luteum-generated hormones in high 
responders. In support of this hypothesis, we found a higher number 
of oocytes generated in those outlier groups categorized as highly 
divergent in terms of hormone fluctuation, while a lower number 
of oocytes were generated by the central categories that display less 
dramatic hormonal variations. Consequently, we would suggest that 
the number of oocytes constitutes one possible component of an 
elevated EP rate. 
Several studies [53,54,56] report the incidence of EP associated 
with ART based on large national databases. These types of studies 
are often less reliable, as they are hampered by in accuracies linked 
to non-owner databases. Therefore, the lack of information available 
for clinical protocols and processes for embryo transfer might impact 
the outcome. In our study, all patients were followed-up by the same 
gynaecological team in just two clinics.
Our study does, however, have some limitations. First, it was 
conducted retrospectively, making several factors difficult to control. 
Although transfers were performed by the same gynaecology and 
embryology team, we could not control interpersonal variation. The 
accuracy of the study would probably be greater if the transfers had 
been carried out by only one gynaecologist and embryologist. We 
did not analyse the incidence of ectopic pregnancy on the degree 
of difficulty on embryo transfer because only 3.9% of cycles were 
considered not easy. Therefore, the sample size is not big enough to 
reach a conclusion. The quantities of culture medium and air used to 
transfer the embryos were consistent.
Due to the long term included in this study, two different culture 
media were used by the clinics. A recent retrospective study pointed 
out that EP might, in part, be influenced by the culture media used 
[57]. However, we found no differences in the EP rate between the 
two culture media employed (data not shown).
Many authors have pointed out a different ectopic pregnancy 
incidence according to embryo stage transference .Some groups 
have associated blasyocyst transference with lower incidence of 
ectopic pregnancy [52,58-59]. Others, have stated out that there 
is no relationship between the embryo stage at the moment of the 
transference and ectopic pregnancy [2,60-61]. Finally others had 
found lower risk of Ectopic Pregnancy when transferring cleavage 
stage embryos [62-63].
Our study has not been designed for analyzing the influence 
between embryo cleavage stage and Ectopic Pregnancy. It is an issue 
which can’t be excluded, indeed, but if we observe the numbers 
of ectopic pregnancy in our study, we can´t find any statistically 
significant difference (in cleavage stage we found 8/482 off ectopic 
pregnancy, it is a 1,5% , and for blastocyst stage, we found 2 EP out of 
133 transference, what means a 1,6% of ectopic pregnancy).
We analyzed a specifically low risk group, to avoid bias induced 
by other possible causes of EP. As might be expected, our conclusions 
cannot therefore be generalized to the IVF population as a whole. 
Future efforts should therefore focus on studying, simultaneously, 
hormone levels and uterine peristalsis, as tubal peristalsis is still 
unable to be measured in vivo. Randomized prospective blind or 
experimental studies are also now required to confirm our findings.
EPs are potentially life-threatening scenarios that occur 
more frequently after assisted reproduction than in spontaneous 
pregnancies. Given their potential severity, any efforts to prevent 
them are desirable. This research provides new mechanistic data for 
EPs in the setting of IVF. The concentration of E2, and its associated 
effects in the early luteal phase, could provide new insights into the 
management of ET. We suggest that patients with high risk EP should 
have their E2 and P4 levels evaluated during the luteal phase. In the 
case these values change markedly, it would be appropriate to defer 
frozen embryo transfer.
To our knowledge, this is the first study to specifically examine 
the association between hormone level variation and the risk of EP. 
Possible implications for uterine peristalsis and tubal function in 
influencing EP risk are still unproven. 
In conclusion, we find that aberrant E2 variation between the 
late follicular phase, and early luteal phase (hCGd and hCG+7), is 
associated with an elevated risk of EP. A high P4 level on hCGd is also 
linked to a risk of EP in fresh embryo transfers.
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